Original Source(s)
Retinal Ischemia as Stroke Warning
May 8, 2026
Related Content
Phase 3 Win for TED Therapy
Amgen’s subcutaneous TEPEZZA meets phase 3 endpoints in thyroid eye disease
May 8, 2026
-
3 min
Vamikibart Shows Early Safety in Uveitic Macular Edema
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026
-
3 min
Chatbots Enter Retinal Care
New research shows how conversational AI might improve patient understanding and engagement in retinal detachment pathways
May 7, 2026
-
3 min
